Learn More http://www.rsna.org/
Save the date for the world’s most comprehensive hematology event of the year, the 59th ASH Annual Meeting and Exposition, in vibrant, fresh, and creative Atlanta. The meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field as well as a global community of more than 25,000 hematology professionals from every subspecialty.
Just like our meeting, Atlanta has something for everyone – and there’s no time like the present to visit the South's largest city. In the middle of an urban resurgence, Atlanta was named one of the New York Times’ 52 places to visit in 2014. Around every corner is a new attraction, restaurant, or shopping opportunity. If you haven't visited in a few years, you haven't really seen Atlanta.
Learn more http://www.hematology.org/Annual-Meeting/
New York City
The Immuno-Oncology 360° summit gives attendees exposure to the entire spectrum of science — from discovery to translational and clinical, as well as, emerging technologies, business aspects, investor relations and trends in the field. Designed by lead advisors Dr Axel Hoos, GSK and Dr James Gulley, NCI, Immuno-Oncology 360° provides the most up-to-date research, data and progress to help IO stakeholders:
In a constantly evolving oncology environment, ESMO continues to expand its educational offer and conference portfolio and is pleased to announce that as of 2018 ESMO is taking on the TAT Congress, which will now be held on an annual basis in Europe.
The goals and the design of phase 1 studies have changed from just safety/toxicity to now include clinical activity/response and biomarker research. This new phase 1 paradigm has already led to rapid, conditional, approval of several new cancer therapeutics showing outstanding clinical activity in early-phase studies.
TAT focuses on early-phase development and translational research. The programme will cover targeted agents, immuno-oncology and combinations ≈ agents. We hope to see you at TAT 2018!
Learn More http://www.esmo.org/Conferences/TAT-2018-Targeted-Anticancer-Therapies
Los Angeles, CA
American Academy of Neurology (AAN) 70th Annual Meeting is organized by American Academy of Neurology (AAN) and would be held during Apr 21 - 28, 2018 at Los Angeles, California, United States Of America. The target audience for this medical event basically for neurologists.
The AAN Annual Meeting is one of the world's largest professional meeting of neurologists, the AAN, will bring into our attention cutting-edge science and research, clinical updates, and many more.
Learn More https://www.asco.org/2018-asco-annual-meeting
The SNMMI Annual Meeting brings together leading molecular imaging and nuclear medicine physicians, radiologists, cardiologists, pharmacists, scientists, lab professionals and technologists representing the world’s top medical and academic institutions and centers.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), headquartered in Reston, Va., is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging. SNMMI strives to be a leader in unifying, advancing and optimizing molecular imaging with an ultimate goal of improving human health. With 18,000 members worldwide, SNMMI represents nuclear and molecular imaging professionals, all of whom are committed to the advancement of the field.
About DIA 2018 Global Annual Meeting
DIA, founded as the Drug Information Association, provides a global, neutral forum where stakeholders can openly and freely exchange knowledgeable information and insights beyond boundaries to advance innovation in health care product development and life cycle management globally. The Global Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. DIA 2018 Global Annual Meeting will host more than 8,000 professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe. DIA 2018 boasts more than 450 exhibiting companies, over 10 tracks, and more than 160 sessions focused on regulatory science, translational medicine, patient engagement, and value and access.
The goal of the DIA 2018 Global Annual Meeting is to provide you and your team with a rare opportunity to build on what you already know in the development of new therapies and accelerate efforts to enhance health and well-being. Where else can you meet with people from around the world, share your views and knowledge, experience cross-functional content with real-world application from top speakers in the industry, and network with peers to build new relationships across multiple disciplines?
Learn more http://www.diaglobal.org/Flagship/DIA-2018